ArticleTherapeutic advances in medical oncology2020

Efficacy and safety of regorafenib as beyond second-line therapy in patients with metastatic colorectal cancer: an adjusted indirect meta-analysis and systematic review.

Yinying Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.